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A corrigendum on
An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by Bjerregaard A-M, Nielsen M, Jurtz V, Barra CM, Hadrup SR, Szallasi Z, et al. Front Immunol 
(2017) 8:1566. doi: 10.3389/fimmu.2017.01566
An outdated version of Supplementary Table 1 was uploaded to the final version of the paper for pub-
lication. This table has not been under peer review and does not include the information described in 
the paper such as the similarity measurement column. The correct Supplementary Table 1 has now 
been published in the original article. The authors apologize for this oversight. This error does not 
change the scientific conclusion of the article in any way.
The original article has been updated.
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